Systolic Time Intervals in the Diagnosis of Heart Failure in Emergency Departement
STA/AHF
Systolic Time Intervals: a Diagnostic Tool of Acute Heart Failure in Emergency Departement Settings
1 other identifier
observational
530
1 country
1
Brief Summary
the gold standard for the diagnostic of acute heart failure is based on clinical, biological (BNP levels) and echocardiographic findings, but still in some cases, the diagnosis is difficult and requires further investigations. BNP dosages and echocardiography are not always available in many medical centers, especially in emergency departements, and are expensive. we investigated the use of alternative methods, such as the systolic time intervals (STI), in the diagnosis of acute heart failure (AHF) in emergency departement patients consulting for dyspnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2012
CompletedFirst Submitted
Initial submission to the registry
May 4, 2014
CompletedFirst Posted
Study publicly available on registry
June 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedJuly 1, 2020
June 1, 2020
5.2 years
May 4, 2014
June 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PEP/EMAT values between the AHF and non AHF groups
compare the PEP/EMAT values between the two study groups: AHF and non-AHF. the diagnosis of AHF is made based on clinical, BNP, and echocardiographic findings.
at admission (an average of 24 hours)
Secondary Outcomes (3)
PEP values between the two study groups
at admission (an average of 24 hours)
compare the EMAT values between the two study groups
at admission (an average of 24 hours)
compare the STI diagnostic performance against BNP
at hospital admission (an average of 24 hours)
Study Arms (2)
AHF group
patients with AHF diagnosed based on clinical, biological and echocardiographic findings. Two sub-groups of patients were identified within HF group: Patients with reduced (\<45%) LVEF (HFrEF) and those with preserved (≥45%) LVEF (HFpEF).
non AHF group
we included patients with acute dyspnea and for whom acute heart failure was excluded
Interventions
STIs were measured using simultaneous recording of the electrocardiogram and acoustic cardiography signals using an analogic numeric system (Biopac Systems, Goleta, CA). A3-minute acoustic cardiographic tracing for all patients was obtained and stored electronically. We measured the electromechanical activation time (EMAT) which is the time between the initial deflection of the electrocardiographic Q wave and the first phonocardiographic complex corresponding to the first heart sound (S1). The left ventricle ejection time (LVET) defined as the interval between the peak components from the S1 and S2 complexes was measured on the same cardiac cycles. All studies were performed in patients in a semi-recumbent position with head at 30 degrees position. For each patient, the acoustic cardiographic parameters were calculated from a 10-second free of artifact recording of data averaging 8 to 12 beats measurements.
Eligibility Criteria
All patients aged more than 18 years old presenting at the ED with non traumatic dyspnea.
You may qualify if:
- non traumatic dyspnea
- age more than 18 years old.
You may not qualify if:
- ECG diagnostic for acute myocardial infarction or ischemic chest pain within the prior 24 hours
- history of a heart transplant
- pericardial effusion
- chest wall deformity suspected of causing dyspnea
- coma, shock,Mechanical Ventilation, vasopressor drugs
- arrhythmia serious and sustained, pace maker severe mitral valve disease, severe pulmonary arterial hypertension
- renal failure with creatinine \>350micromol/l
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nouira Semir
Monastir, Emergency Department Monastir, Tunisia 5000, 5000, Tunisia
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nouira Samir, Professor
University hospital of Monastir
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 4, 2014
First Posted
June 11, 2014
Study Start
October 2, 2012
Primary Completion
December 31, 2017
Study Completion
December 31, 2019
Last Updated
July 1, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share